86 related articles for article (PubMed ID: 22554692)
1. In vitro screening of NADPH oxidase inhibitors and in vivo effects of L-leucinethiol on experimental autoimmune encephalomyelitis-induced mice.
Kandagaddala LD; Kang MJ; Haque MM; Im HY; Seo JE; Chung BC; Jung BH; Patterson TA; Kwon OS
J Neurol Sci; 2012 Jul; 318(1-2):36-44. PubMed ID: 22554692
[TBL] [Abstract][Full Text] [Related]
2. Expression and activation of matrix metalloproteinase-9 and NADPH oxidase in tissues and plasma of experimental autoimmune encephalomyelitis in mice.
Kandagaddala LD; Kang MJ; Chung BC; Patterson TA; Kwon OS
Exp Toxicol Pathol; 2012 Jan; 64(1-2):109-14. PubMed ID: 20810258
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.
Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; Castañon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP
Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971
[TBL] [Abstract][Full Text] [Related]
4. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
[TBL] [Abstract][Full Text] [Related]
5. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
[TBL] [Abstract][Full Text] [Related]
6. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination.
Furlan R; Martino G; Galbiati F; Poliani PL; Smiroldo S; Bergami A; Desina G; Comi G; Flavell R; Su MS; Adorini L
J Immunol; 1999 Sep; 163(5):2403-9. PubMed ID: 10452974
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of sesame oil in ameliorating experimental autoimmune encephalomyelitis in C57BL/6 mice.
Ghazavi A; Mosayebi G
Phytother Res; 2012 Jan; 26(1):34-8. PubMed ID: 21538630
[TBL] [Abstract][Full Text] [Related]
8. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).
Musgrave T; Benson C; Wong G; Browne I; Tenorio G; Rauw G; Baker GB; Kerr BJ
Brain Behav Immun; 2011 Nov; 25(8):1677-88. PubMed ID: 21723939
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis.
Fontes LB; Dos Santos Dias D; de Carvalho LS; Mesquita HL; da Silva Reis L; Dias AT; Da Silva Filho AA; do Amaral Corrêa JO
J Pharm Pharmacol; 2014 Jun; 66(6):886-94. PubMed ID: 24447171
[TBL] [Abstract][Full Text] [Related]
10. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
[TBL] [Abstract][Full Text] [Related]
11. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
12. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
13. Effects of an aqueous extract of North American ginseng on MOG(35-55)-induced EAE in mice.
Bowie LE; Roscoe WA; Lui EM; Smith R; Karlik SJ
Can J Physiol Pharmacol; 2012 Jul; 90(7):933-9. PubMed ID: 22720838
[TBL] [Abstract][Full Text] [Related]
14. Myelin oligodendrocyte glycoprotein induces aquaporin-4 autoantibodies in mouse experimental autoimmune encephalomyelitis.
Wu X; Zhou M; Ding H; Xu S; Wang C; Chan P
J Neuroimmunol; 2013 Aug; 261(1-2):1-6. PubMed ID: 23707078
[TBL] [Abstract][Full Text] [Related]
15. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
[TBL] [Abstract][Full Text] [Related]
16. Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood-brain barrier permeability in middle-aged mice.
Seo JE; Hasan M; Han JS; Kang MJ; Jung BH; Kwok SK; Kim HY; Kwon OS
J Neuroimmunol; 2015 Oct; 287():43-53. PubMed ID: 26439961
[TBL] [Abstract][Full Text] [Related]
17. A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.
Giacoppo S; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E
Daru; 2015 Oct; 23():48. PubMed ID: 26489494
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
Feinstein DL; Galea E; Gavrilyuk V; Brosnan CF; Whitacre CC; Dumitrescu-Ozimek L; Landreth GE; Pershadsingh HA; Weinberg G; Heneka MT
Ann Neurol; 2002 Jun; 51(6):694-702. PubMed ID: 12112074
[TBL] [Abstract][Full Text] [Related]
19. Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis.
Chiba K; Kataoka H; Seki N; Shimano K; Koyama M; Fukunari A; Sugahara K; Sugita T
Int Immunopharmacol; 2011 Mar; 11(3):366-72. PubMed ID: 20955831
[TBL] [Abstract][Full Text] [Related]
20. A leading role for NADPH oxidase in an in-vitro study of experimental autoimmune encephalomyelitis.
Seo JE; Hasan M; Rahaman KA; Kang MJ; Jung BH; Kwon OS
Mol Immunol; 2016 Apr; 72():19-27. PubMed ID: 26928315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
